Objetivo
DESIRE will focus on epileptogenic developmental disorders EDD, i.e. early onset epilepsies whose origin is closely related to developmental brain processes. A major cause of EDD are malformations of cortical development (MCD), either macroscopic or subtle. EDD are often manifested as epileptic encephalopathies (EE), i.e. conditions in which epileptic activity itself may contribute to severe cognitive and behavioral impairments. EDD are the most frequent drug-resistant pediatric epilepsies carrying a lifelong perspective of disability and reduced quality of life. Although EDD collectively represent a major medical and socio-economic burden, their molecular diagnosis, pathogenic mechanisms (PM) and rationale treatment are poorly understood. Specific objectives of DESIRE are to advance the state of the art with respect to: (1) the genetic and epigenetic causes and PM of EDD, particularly epileptogenic MCD, to elucidate molecular networks and disrupted protein complexes and search for common bases for these apparently heterogeneous disorders. (2) the diagnostic tools (biomarkers) and protocols through the study of a unique and well-characterized cohort of children to provide standardized diagnosis for patient stratification and research across Europe. (3) treatment of EDD using randomized, multidisciplinary clinical protocols and testing preclinical strategies in experimental models to also address novel preventative strategies. The workplan spans from clinical observation, to whole exome studies, cellular and animal models and basic research, identification of biomarkers and improvement of diagnostic methods, and back to the clinical trials and assessment of innovative, targeted treatment strategies. The consortium partners have an outstanding track record in genetics, basic neurophysiology, neuropathology and clinical research. Specialized expertise will be made available by the SMEs involved to develop novel diagnostic tools for tailored treatment approaches.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2013-INNOVATION-1
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
50121 Florence
Italia
Ver en el mapa
Participantes (27)
20133 Milano
Ver en el mapa
75654 Paris
Ver en el mapa
91054 Erlangen
Ver en el mapa
37129 Verona
Ver en el mapa
75794 Paris
Ver en el mapa
16163 Genova
Ver en el mapa
28006 Madrid
Ver en el mapa
WC2R 2LS London
Ver en el mapa
10117 Berlin
Ver en el mapa
50937 Koeln
Ver en el mapa
WC1E 6BT London
Ver en el mapa
L69 7ZX Liverpool
Ver en el mapa
La participación finalizó
1050 Bruxelles / Brussel
Ver en el mapa
24118 Kiel
Ver en el mapa
3104 Melbourne
Ver en el mapa
2080 L-Imsida
Ver en el mapa
50019 Sesto Fiorentino Fi
Ver en el mapa
31021 MOGLIANO VENETO
Ver en el mapa
La participación finalizó
89077 ULM
Ver en el mapa
72076 Tubingen
Ver en el mapa
2333 CH LEIDEN
Ver en el mapa
20154 Milano
Ver en el mapa
20123 Milano
Ver en el mapa
00165 Roma
Ver en el mapa
16147 Genova
Ver en el mapa
75015 PARIS 15
Ver en el mapa
49035 Angers Cedex 01
Ver en el mapa